Fig. 1
From: STK16 promoted colorectal cancer progress in a c-MYC signaling-dependent manner
STK16 Upregulation in Colorectal Cancer. A, B. Investigation of STK16 expression levels in colorectal cancer using TCGA database. C. Representative IHC images of colorectal cancer tissues and adjacent matched normal tissues. D, E. Statistical analysis of STK16 expression levels in colorectal cancer tissues and adjacent matched normal tissues. F. Immunoblotting (IB) assays to assess STK16 expression in colorectal cancer tissues and adjacent matched normal tissues. G. Representative IHC images of colorectal cancer tissues. H, I. Statistical analysis of STK16 expression levels in colorectal cancer patients grouped by T stages (H) or clinical stages (I). J. Kaplan-Meier plotter to analyze overall survival time of colorectal cancer patients grouped by STK16 expression. K. Kaplan-Meier Plot drawn using TCGA database, with patients grouped by STK16 expression. All IB assays were conducted three times, and consistent results were obtained. Statistical analysis was performed using Student’s t-test